medigraphic.com
ISSN 0016-3813 (Print)

2013, Number 1

<< Back Next >>

Gac Med Mex 2013; 149 (1)

Acute adverse effects in transfusion. Proposals for the hemosurveillance system

Baptista GH

Language: Spanish
References: 33
Page: 94-101
PDF size: 113.82 Kb.


ABSTRACT

The management model based on risk prevention has become a major influence in shaping policies for transfusion safety. There are approximately sixty interactions between the health worker and the patient during the transfusion process, representing the number of times where you have the opportunity to make a mistake.
We present an analysis of the weaknesses of the National Blood System, with particular attention to the haemovigilance donor and patient. The proposals include the implementation of the National Blood containing the need to establish from the National Blood Safety, significant changes in the regulatory framework and the internal regulations of the Ministry of Health, the CNTS and COFEPRIS. Is required to promote and coordinate the collection of accurate information from the committees of transfusion medicine, which will be accompanied by an initial diagnosis from the National Survey of Blood. Requires notice to other forms of funding to ensure the viability of the projects operating blood bank. Finally, as a strategic resource, the blood is of public, so access should not be restricted.


REFERENCES

  1. Leach Bennett J, Blajchman MA, Delage G, Fearon M. Devine D. Proceedings of a consensus conference: risk-based decision making for blood safety. Transfus Med Rev. 2011;25:267-92.

  2. Stein J, Besley J, Brook C, et al. Risk-based decision-making for blood safety: preliminary report of a consensus conference. Vox Sang. 2011;101:277-81.

  3. Wilson K. A framework for applying the precautionary principle to transfusion safety. Transfus Med Rev. 2011;25:177-83.

  4. Volkow P, Pérez-Padilla R, Del-Río C, Mohar A. The role of commercial plasmapheresis banks on the AIDS epidemic in Mexico. Rev Invest Clin. 1998;50:221-6.

  5. Ávila C, Stetler HC, Sepúlveda J, et al. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico. AIDS. 1989;3:631-3.

  6. Baptista-González HB. Lo que no sabemos y lo que debemos saber acerca de las pruebas moleculares en el tamiz de infecciones transmitidas por infección en donadores de sangre en México. Rev Mex Med Transf. 2009;2:30-40.

  7. Méndez-Sánchez N, Gutiérrez-Grobe Y, Kobashi-Margain RA. Epidemiology of HCV infection in Latin America. Ann Hepatol. 2010; 9(Suppl): 27-9.

  8. Fujii Y, Shibata Y, Miyata S, et al. Consecutive national surveys of ABOincompatible blood transfusion in Japan. Vox Sang. 2009;97:240-6.

  9. Fastman BR, Kaplan HS. Errors in transfusion medicine: have we learned our lesson? Mt Sinai J Med. 2011;78:854-64.

  10. Anders S, Miller A, Joseph P, et al. Blood product positive patient identification: comparative simulation-based usability test of two commercial products. Transfusion. 2011;51:2311-8.

  11. Gallagher-Swann M, Ingleby B, Cole C, Barr A. Improving transfusion practice: ongoing education and audit at two tertiary speciality hospitals in Western Australia. Transfus Med. 2011;21:51-6.

  12. De Vries RR, Faber JC, Strengers PF. Board of the International Haemovigilance Network. Haemovigilance: an effective tool for improving transfusion practice. Vox Sang. 2011;100:60-7.

  13. Dunbar NM, Walsh SJ, Szczepiorkowski ZM. Transfusion reaction reporting in the era of hemovigilance: where form meets function. Transfusion. 2011;51:2583-7.

  14. Roberts DJ. Public policy, blood safety and haemovigilance. Transfus Med. 2011;21:357-8.

  15. Norma oficial mexicana, NOM-003-SSA2-1993, para la disposición de sangre humana y sus componentes con fines terapéuticos. Diario Oficial de la Federación, 18 de julio de 1994.

  16. Owens W, Gagliardi K, Lauzon D. Building better hospital transfusion committees for Ontario. Transfus Apher Sci. 2012;46:323-7.

  17. Follea G, De Wit J, Rouger P. European Blood Alliance (EBA) and EuroNet TMS: what challenges for the transfusion of tomorrow? Transfus Clin Biol. 2011;18:106-14.

  18. Elhence P, Veena S, Sharma RK, Chaudhary RK. Root cause analysis of transfusion error: identifying causes to implement changes. Transfusion. 2010;50:2772-7.

  19. Murphy MF, Stanworth SJ, Yazer M. Transfusion practice and safety: current status and possibilities for improvement. Vox Sang. 2011; 100:46-59.

  20. Davis RE, Vincent CA, Murphy MF. Blood transfusion safety: the potential role of the patient. Transfus Med Rev. 2011;25:12-23.

  21. Sharma G, Parwani AV, Raval JS, Triulzi DJ, Benjamin RJ, Pantanowitz L. Contemporary issues in transfusion medicine informatics. J Pathol Inform. 2011;2:3.

  22. Whitehurst JM, Schrider J, Leonard D, Horvath MM, Cozart H, Ferranti J. Towards the creation of a flexible classification scheme for voluntarily reported transfusion and laboratory safety events. J Biomed Semantics. 2012;3:4-14.

  23. Sandid I. European regulation on blood and blood components. Transfus Clin Biol. 2010;17:310-4.

  24. Lipton KS, Otter J. AABB and FDA: a shared history of patient safety. Transfusion. 2010;50:1643-6.

  25. Hansen-Magnusson H. Governance in the European union: the European Blood Directive as an evolving practice. Clin Lab Med. 2010;30: 489-97.

  26. Seifried E, Mueller MM. The present and future of transfusion medicine. Blood Transfus. 2011;9:371-6.

  27. Verlicchi F, Facco G, Macri M, Antoncecchi S, Bonomo P. Blood transfusion practice: a nationwide survey in Italy. Blood Transfus. 2011;9:430-5.

  28. Centers for Disease Control. Progress toward strengthening national blood transfusion services – 14 countries, 2008-2010. MMWR Morb Mortal Wkly Rep. 2011;60:1577-82.

  29. Wiersum-Osselton JC. International databases: usefulness and limitations in hemovigilance. Transfus Clin Biol. 2010;17:306-9.

  30. LaRocco M, Brient K. Interdisciplinary process improvement for enhancing blood transfusion safety. J Healthc Qual. 2010;32:29-34.

  31. AuBuchon JP, Linauts S, Vaughan M, Wagner J, Delaney M, Nester T. Evolution in a centralized transfusion service. Transfusion. 2011;51:2750-7.

  32. Franchini M. Error reporting in transfusion medicine: an important tool to improve patient safety. Clin Chem Lab Med. 2012;6:1-2.

  33. Rautonen J. Self-sufficiency, free trade and safety. Biologicals. 2010; 38:97-9.




2020     |     www.medigraphic.com